Skip to content

A cluster randomized pilot trial evaluating the feasibility of intervening heart failure patients with influenza vaccines

A cluster randomized pilot trial evaluating the feasibility of intervening heart failure patients with influenza vaccines

Status
Recruiting
Phases
Phase 4
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2000039081
Enrollment
Unknown
Registered
2020-10-16
Start date
2020-11-01
Completion date
Unknown
Last updated
2021-11-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Heart Failure

Interventions

Intervention group:Education to the health care team and patients
Intervention group:Provision of free vaccine on the day of discharge
Intervention group:Provision of immunization service inside hospital on the day of discharge

Sponsors

Heart Health Research Center (HHRC)
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: Inclusion criteria for research institutions: 1. Be able to receive, treat and recruit patients with heart failure; 2. More than 40 patients with heart failure could be treated every month during the recruitment period; 3. Medical team members are willing to cooperate in this study, and can control the loss of follow-up rate = 18 years) who were discharged from the participating hospitals and diagnosed with heart failure during the whole recruitment period; 2. Patients with NYHA classification III-IV during hospitalization; 3. The patients who voluntarily participated in the study signed the informed consent.

Exclusion criteria

Exclusion criteria: Site exclusion criteria: 1.Participating in vaccination-related or other HF patient outcome improvement programs that might confound study outcomes. Patient exclusion criteria: 1.Known allergy to influenza vaccine; 2.Pregnant women.

Design outcomes

Primary

MeasureTime frame
Influenza vaccine coverage rate (VCR);

Secondary

MeasureTime frame
Number of patients recruited during study period;Rate of patient follow-up;Death or readmission for HF over 3 months follow-up;

Countries

China

Contacts

Public ContactXin Du

George Heart Health Institute of Beijing Heart Association

duxin@hhresearch.cn+86 13370103558

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 9, 2026